Inhibition of (-)-trans-(1S,2S)-U50488 hydrochloride by its enantiomer in white mice - A placebo-controlled, randomized study

Forschende Komplementarmedizin und Klassische Naturheilkunde

Volumn 11, Issue 3, 2004, Pages 144-149

  Kuzeff, R M ^a,c   Topashka Ancheva, M N ^b   Mecheva, R P ^b  

^a SWINBURNE UNIVERSITY OF TECHNOLOGY   (Australia)

^b INSTITUTE OF BIODIVERSITY AND ECOSYSTEM RESEARCH   (Bulgaria)

^c NONE   (Australia)

Author keywords

Bioassay; Enantiomer; Homeopathy; Isomer; Isopathy; Randomized controlled trial; Stereoisomer; U50488

Indexed keywords

3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDE; PLACEBO;

ANIMAL EXPERIMENT; ARTICLE; CAUSE OF DEATH; CHI SQUARE TEST; CONTROLLED STUDY; DRUG EFFECT; DRUG POTENCY; ENANTIOMER; HOMEOPATHY; LD 50; LOGISTIC REGRESSION ANALYSIS; MOUSE; NONHUMAN; STEREOISOMERISM; SURVIVAL RATE; ANIMAL; CHEMISTRY; DOUBLE BLIND PROCEDURE; DRUG ANTAGONISM; INSTITUTE FOR CANCER RESEARCH MOUSE; INTRAPERITONEAL DRUG ADMINISTRATION; METHODOLOGY; PROSPECTIVE STUDY; RANDOMIZATION; STATISTICAL MODEL; SURVIVAL;

3,4-DICHLORO-N-METHYL-N-(2-(1-PYRROLIDINYL)-CYCLOHEXYL)-BENZENEACETAMIDE, (TRANS)-ISOMER; ANIMALS; DOUBLE-BLIND METHOD; HOMEOPATHY; INJECTIONS, INTRAPERITONEAL; LETHAL DOSE 50; LOGISTIC MODELS; MICE; MICE, INBRED ICR; PLACEBOS; PROSPECTIVE STUDIES; RANDOM ALLOCATION; STEREOISOMERISM; SURVIVAL ANALYSIS;

EID: 4644225202     PISSN: 14247364     EISSN: None     Source Type: Journal    
DOI: 10.1159/000079443     Document Type: Article

References (12)

1. Kuzeff RM, Topashka-Ancheva MN, Mecheva RP: Inhibition of (-)-propranolol hydrochloride by its enantiomer in white mice. Forsch Komplementärmed Klass Naturheilkd 2003;10:309-314.
2. Kuzeff RM, Mecheva RP, Topashka-Ancheva MN: Inhibition of (-)-propranolol hydrochloride by its enantiomer in white mice - a placebo-controlled randomized study. Forsch Komplementärmed Klass Naturheilkd 2004;11:14-19.
3. Su X, Joshi SK, Kardos S, Gebhart GF: Sodium channel blocking actions of the kappa-opioid receptor agonist U50488 contribute to its visceral antinociceptive effects. J Neurophysiol 2002;87:1271-1279.
4. Fisher P, House I, Belon P, Turner P: The influence of the homoeopathic remedy plumbum metallicum on the excretion kinetics of lead in rats. Hum Toxicol 1987;6:321-324.
5. Jonas WB: Do homeopathic nosodes protect against infection? An experimental test. Altern Ther Health Med 1999;5:36-40.
6. Jonas W, Lin Y, Tortella F: Neuroprotection from glutamate toxicity with ultra-low dose glutamate. Neuroreport 2001;12:335-339.
7. Cazin JC, Cazin M, Gaborit JL, Chaoui A, Boiron J, Belon P, Cherrault Y, Papapanayoton C: A study of the effect of decimal and centesimal dilutions of arsenic on the retention and mobilization of arsenic in the rat. Hum Toxicol 1987;6:315.
8. Watson I: A Guide to the Methodologies of Homoeopathy, revised ed. Kendall, UK, Cutting Edge Publications, 1999.
9. Blackie Foundation Trust Protocol. London, Blackie Foundation Trust, 1994.
10. Budavari S: The Merck Index. An Encylopedia of Chemicals, Drugs and Biologicals, 12th ed. Whitehouse Station, NJ, USA, Merck Research Laboratories, 1996.
11. Whittow GC (ed): Comparative Physiology of Thermoregulation - Mammals 2, Minimal Metabolism and Body Size. New York, Academic Press, 1971, pp 30-36.
12. Baumgartner S, Heusser P, Thurneysen A: Methodological standards and problems in preclinical homeopathic potency research. Forsch Komplementärmed 1998;5:27-32.